255 related articles for article (PubMed ID: 18089818)
21. Structure of a BRCA1-BARD1 heterodimeric RING-RING complex.
Brzovic PS; Rajagopal P; Hoyt DW; King MC; Klevit RE
Nat Struct Biol; 2001 Oct; 8(10):833-7. PubMed ID: 11573085
[TBL] [Abstract][Full Text] [Related]
22. Cancer predisposing BARD1 mutations in breast-ovarian cancer families.
Ratajska M; Antoszewska E; Piskorz A; Brozek I; Borg Å; Kusmierek H; Biernat W; Limon J
Breast Cancer Res Treat; 2012 Jan; 131(1):89-97. PubMed ID: 21344236
[TBL] [Abstract][Full Text] [Related]
23. Identification of novel alternatively spliced BRCA1-associated RING domain (BARD1) messenger RNAs in human peripheral blood lymphocytes and in sporadic breast cancer tissues.
Lombardi G; Falaschi E; Di Cristofano C; Naccarato AG; Sensi E; Aretini P; Roncella M; Bevilacqua G; Caligo MA
Genes Chromosomes Cancer; 2007 Sep; 46(9):791-5. PubMed ID: 17497650
[TBL] [Abstract][Full Text] [Related]
24. BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity.
Nishikawa H; Wu W; Koike A; Kojima R; Gomi H; Fukuda M; Ohta T
Cancer Res; 2009 Jan; 69(1):111-9. PubMed ID: 19117993
[TBL] [Abstract][Full Text] [Related]
25. Nuclear-cytoplasmic shuttling of BARD1 contributes to its proapoptotic activity and is regulated by dimerization with BRCA1.
Rodriguez JA; Schüchner S; Au WW; Fabbro M; Henderson BR
Oncogene; 2004 Mar; 23(10):1809-20. PubMed ID: 14647430
[TBL] [Abstract][Full Text] [Related]
26. BARD1 homozygous deletion, a possible alternative to BRCA1 mutation in basal breast cancer.
Sabatier R; Adélaïde J; Finetti P; Ferrari A; Huiart L; Sobol H; Chaffanet M; Birnbaum D; Bertucci F
Genes Chromosomes Cancer; 2010 Dec; 49(12):1143-51. PubMed ID: 20842729
[TBL] [Abstract][Full Text] [Related]
27. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation.
Hashizume R; Fukuda M; Maeda I; Nishikawa H; Oyake D; Yabuki Y; Ogata H; Ohta T
J Biol Chem; 2001 May; 276(18):14537-40. PubMed ID: 11278247
[TBL] [Abstract][Full Text] [Related]
28. A truncated splice variant of human BARD1 that lacks the RING finger and ankyrin repeats.
Tsuzuki M; Wu W; Nishikawa H; Hayami R; Oyake D; Yabuki Y; Fukuda M; Ohta T
Cancer Lett; 2006 Feb; 233(1):108-16. PubMed ID: 15878232
[TBL] [Abstract][Full Text] [Related]
29. Expression of oncogenic BARD1 isoforms affects colon cancer progression and correlates with clinical outcome.
Zhang YQ; Pilyugin M; Kuester D; Leoni VP; Li L; Casula G; Zorcolo L; Schneider-Stock R; Atzori L; Irminger-Finger I
Br J Cancer; 2012 Aug; 107(4):675-83. PubMed ID: 22814582
[TBL] [Abstract][Full Text] [Related]
30. Expression of an Oncogenic BARD1 Splice Variant Impairs Homologous Recombination and Predicts Response to PARP-1 Inhibitor Therapy in Colon Cancer.
Ozden O; Bishehsari F; Bauer J; Park SH; Jana A; Baik SH; Sporn JC; Staudacher JJ; Yazici C; Krett N; Jung B
Sci Rep; 2016 May; 6():26273. PubMed ID: 27197561
[TBL] [Abstract][Full Text] [Related]
31. HDAC inhibitors repress BARD1 isoform expression in acute myeloid leukemia cells via activation of miR-19a and/or b.
Lepore I; Dell'Aversana C; Pilyugin M; Conte M; Nebbioso A; De Bellis F; Tambaro FP; Izzo T; Garcia-Manero G; Ferrara F; Irminger-Finger I; Altucci L
PLoS One; 2013; 8(12):e83018. PubMed ID: 24349422
[TBL] [Abstract][Full Text] [Related]
32. BRCA1 DNA-binding activity is stimulated by BARD1.
Simons AM; Horwitz AA; Starita LM; Griffin K; Williams RS; Glover JN; Parvin JD
Cancer Res; 2006 Feb; 66(4):2012-8. PubMed ID: 16489000
[TBL] [Abstract][Full Text] [Related]
33. Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells.
Ueki T; Park JH; Nishidate T; Kijima K; Hirata K; Nakamura Y; Katagiri T
Cancer Res; 2009 Nov; 69(22):8752-60. PubMed ID: 19887602
[TBL] [Abstract][Full Text] [Related]
34. BARD1 expression predicts outcome in colon cancer.
Sporn JC; Hothorn T; Jung B
Clin Cancer Res; 2011 Aug; 17(16):5451-62. PubMed ID: 21693656
[TBL] [Abstract][Full Text] [Related]
35. RNA assay identifies a previous misclassification of BARD1 c.1977A>G variant.
Rofes P; Pineda M; Feliubadaló L; Menéndez M; de Cid R; Gómez C; Montes E; Capellá G; Brunet J; Del Valle J; Lázaro C
Sci Rep; 2021 Nov; 11(1):22948. PubMed ID: 34824355
[TBL] [Abstract][Full Text] [Related]
36. Expression of BARD1 β Isoform in Selected Pediatric Tumors.
Jasiak A; Krawczyńska N; Iliszko M; Czarnota K; Buczkowski K; Stefanowicz J; Adamkiewicz-Drożyńska E; Cichosz G; Iżycka-Świeszewska E
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33530592
[TBL] [Abstract][Full Text] [Related]
37. BRCA1-dependent and independent functions of BARD1.
Irminger-Finger I; Leung WC
Int J Biochem Cell Biol; 2002 Jun; 34(6):582-7. PubMed ID: 11943588
[TBL] [Abstract][Full Text] [Related]
38. BARD1 regulates BRCA1-mediated transactivation of the p21WAF1/CIP1 and Gadd45 promoters.
Fabbro M; Henderson BR
Cancer Lett; 2008 May; 263(2):189-96. PubMed ID: 18243530
[TBL] [Abstract][Full Text] [Related]
39. Nucleophosmin/B23 is a candidate substrate for the BRCA1-BARD1 ubiquitin ligase.
Sato K; Hayami R; Wu W; Nishikawa T; Nishikawa H; Okuda Y; Ogata H; Fukuda M; Ohta T
J Biol Chem; 2004 Jul; 279(30):30919-22. PubMed ID: 15184379
[TBL] [Abstract][Full Text] [Related]
40. Literature Review of
Alenezi WM; Fierheller CT; Recio N; Tonin PN
Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32726901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
